VolitionRX

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VolitionRX and other ETFs, options, and stocks.

About VNRX

VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid.

CEO

Cameron John Reynolds

CEOCameron John Reynolds

Employees

Employees83

Headquarters

Henderson, Nevada

HeadquartersHenderson, Nevada

Founded

1998

Founded1998

Employees

Employees83

VNRX Key Statistics

Market cap

82.59M

Market cap82.59M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

69.43K

Average volume69.43K

High today

$1.50

High today$1.50

Low today

$1.44

Low today$1.44

Open price

$1.50

Open price$1.50

Volume

75.65K

Volume75.65K

52 Week high

$4.14

52 Week high$4.14

52 Week low

$1.44

52 Week low$1.44

VNRX Earnings

-$0.15

-$0.06

$0.03

$0.12

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, After Hours

ActualExpected Nov 9, After Hours

VolitionRX

Why Robinhood?

VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. Show more

VNRX Key Statistics

VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid.